Document Detail


Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
MedLine Citation:
PMID:  20554944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Patients with glioblastoma multiforme, the most aggressive form of glioma, have a median survival of approximately 12 months. Calcium (Ca(2+)) signaling plays an important role in cell proliferation, and some members of the Ca(2+)-permeable transient receptor potential canonical (TRPC) family of channel proteins have demonstrated a role in the proliferation of many types of cancer cells. In this study, we investigated the role of TRPC6 in cell cycle progression and in the development of human glioma. METHODS: TRPC6 protein and mRNA expression were assessed in glioma (n = 33) and normal (n = 17) brain tissues from patients and in human glioma cell lines U251, U87, and T98G. Activation of TRPC6 channels was tested by platelet-derived growth factor-induced Ca(2+) imaging. The effect of inhibiting TRPC6 activity or expression using the dominant-negative mutant TRPC6 (DNC6) or RNA interference, respectively, was tested on cell growth, cell cycle progression, radiosensitization of glioma cells, and development of xenografted human gliomas in a mouse model. The green fluorescent protein (GFP) and wild-type TRPC6 (WTC6) were used as controls. Survival of mice bearing xenografted tumors in the GFP, DNC6, and WTC6 groups (n = 13, 15, and 13, respectively) was compared using Kaplan-Meier analysis. All statistical tests were two-sided. RESULTS: Functional TRPC6 was overexpressed in human glioma cells. Inhibition of TRPC6 activity or expression attenuated the increase in intracellular Ca(2+) by platelet-derived growth factor, suppressed cell growth and clonogenic ability, induced cell cycle arrest at the G2/M phase, and enhanced the antiproliferative effect of ionizing radiation. Cyclin-dependent kinase 1 activation and cell division cycle 25 homolog C expression regulated the cell cycle arrest. Inhibition of TRPC6 activity also reduced tumor volume in a subcutaneous mouse model of xenografted human tumors (P = .014 vs GFP; P < .001 vs WTC6) and increased mean survival in mice in an intracranial model (P < .001 vs GFP or WTC6). CONCLUSIONS: In this preclinical model, TRPC6 channels were essential for glioma development via regulation of G2/M phase transition. This study suggests that TRPC6 might be a new target for therapeutic intervention of human glioma.
Authors:
Xia Ding; Zhuohao He; Kechun Zhou; Ju Cheng; Hailan Yao; Dongliang Lu; Rong Cai; Yening Jin; Bin Dong; Yinghui Xu; Yizheng Wang
Related Documents :
20392944 - Cdk5 suppresses the neuronal cell cycle by disrupting the e2f1-dp1 complex.
14641104 - Modelling the controls of the eukaryotic cell cycle.
7969164 - The saccharomyces cerevisiae checkpoint gene bub1 encodes a novel protein kinase.
6825114 - Mopc 104e plasmacytoma functional heterogeneity and maturational potential in culture.
12215014 - Extramedullary hematopoiesis in hereditary spherocytosis deficient in ankyrin: a case r...
18406784 - Roles of estrogen and progesterone in normal mammary gland development insights from pr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-06-16
Journal Detail:
Title:  Journal of the National Cancer Institute     Volume:  102     ISSN:  1460-2105     ISO Abbreviation:  J. Natl. Cancer Inst.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-21     Completed Date:  2010-08-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503089     Medline TA:  J Natl Cancer Inst     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1052-68     Citation Subset:  IM    
Affiliation:
Laboratory of Neural Signal Transduction, Institute of Neuroscience, Shanghai Institute for Biological Sciences, State Key Laboratory of Neuroscience, Chinese Academy of Sciences, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoviridae
Animals
Base Sequence
Brain Neoplasms / genetics,  metabolism*,  pathology
Cell Division*
Cell Line, Tumor
Cell Transformation, Neoplastic / genetics,  immunology,  metabolism*
Disease Models, Animal
Flow Cytometry
Fluorescent Antibody Technique, Indirect
G2 Phase*
Gene Expression Regulation, Neoplastic
Genetic Vectors
Glioma / genetics,  metabolism*,  pathology
Humans
Immunoblotting
Immunohistochemistry
In Situ Hybridization
Lentivirus
Mice
Molecular Sequence Data
Phenotype
RNA, Messenger / metabolism
RNA, Small Interfering
Reverse Transcriptase Polymerase Chain Reaction
TRPC Cation Channels / antagonists & inhibitors,  genetics,  immunology,  metabolism*
Transplantation, Heterologous
Up-Regulation
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/RNA, Small Interfering; 0/TRPC Cation Channels; 0/TRPC3 cation channel; 0/TRPC6 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tamoxifen and the Factor V Leiden Mutation.
Next Document:  Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast c...